Downstream Processing Featured Articles

51. New Cell Type Developed For Possible Treatment Of Alzheimer's And Other Brain Diseases 11/7/2012

    UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimer’s.

52. Synergies For Equipping The Single-Use Bioproduction Suite 10/7/2006
    The growth of biopharmaceuticals entering the market has served to change the appearance of the bioproduction suite
53. Putting Capillary Electrophoresis to Work 3/8/1999
    It's been over 10 years since the first commercial instrument for capillary electrophoresis (CE) was introduced with a fanfare and a list of promises to revolutionize the world of separation science...
54. New Protein A Media Boosts Productivity In Monoclonal And Polyclonal Antibody Capture, Lowers Costs 11/3/2011
    Novasep, a leading supplier of manufacturing solutions to the life sciences industries, announces recently the launch of AbSolute High Cap, a new generation protein A media, based on modified silica.
55. Scientists Find A New Way To Boost Common Cancer Drugs 1/14/2013

    Shutting down a specific pathway in cancer cells appears to improve the ability of common drugs to wipe those cells out, according to new research from scientists at Fox Chase Cancer Center, published in the January issue of Cancer Discovery.

56. Scientists Discover Why Some Proteins Are Speedier Than Others 3/11/2013

    Scientists at the University of Bath have solved a problem that has frustrated biologists for years – why different parts of proteins are made at different rates.

57. AB SCIEX And Indigo Team Up To Accelerate Adoption Of Next-Generation Mass Spectrometry For Clinical Research, Forensic Toxicology And Clinical Trials 1/18/2012
    AB SCIEX and Indigo BioSystems recently announced an agreement to jointly market mass spectrometry solutions that streamline data acquisition and automate data review to ensure high quality results in clinical research and forensic toxicology as well as pre-clinical and clinical trials of new drugs.
58. MicroRNAs Can Convert Normal Cells Into Cancer Promoters 11/21/2012

    Unraveling the mechanism that ovarian cancer cells use to change normal cells around them into cells that promote tumor growth has identified several new targets for treatment of this deadly disease.

59. Genetic Markers ID Second Alzheimer's Pathway 4/4/2013

    Researchers at Washington University School of Medicine in St. Louis have identified a new set of genetic markers for Alzheimer’s that points to a second pathway through which the disease develops. By Jim Dryden

60. Launch Of A New Protein A Chromatography Resin For Purification Of Antibody Drugs 10/2/2012

    Kaneka Corporation (Osaka, Japan; President: Kimikazu Sugawara ) announces the launch of KANEKA KanCapA, a new Protein A Chromatography Resin for the purification of therapeutic antibodies. 'KANEKA KanCapA' exhibits high antibody adsorbing capacity and alkaline resistance.